Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 6:46 pm Purchase |
2025-03-31 | 13G | Whitehawk Therapeutics Inc WHWK |
ORBIMED ADVISORS LLC | 4,166,000 8.900% |
4,166,000 (New Position) |
Filing History |
| 2025-05-15 3:53 pm Sale |
2025-03-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Point72 Asset Management, L.P. | 5,087 0.000% |
-1,465,224 (-99.65%) |
Filing History |
| 2025-03-11 7:22 pm Purchase |
2025-03-04 | 13G | Whitehawk Therapeutics Inc WHWK |
SUVRETTA CAPITAL MANAGEMENT LLC | 4,727,510 9.990% |
4,727,510 (New Position) |
Filing History |
| 2025-03-10 4:30 pm Purchase |
2025-03-04 | 13G | Whitehawk Therapeutics Inc WHWK |
ABG WTT-Ceribell Limited | 2,914,605 6.300% |
2,914,605 (New Position) |
Filing History |
| 2025-03-06 5:55 pm Purchase |
2025-03-04 | 13D | Whitehawk Therapeutics Inc WHWK |
Desai Neil | 2,272,941 4.900% |
9,375 (+0.41%) |
Filing History |
| 2025-03-05 3:58 pm Unchanged |
2025-03-05 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 4.980% |
0 (Unchanged) |
Filing History |
| 2025-03-04 5:58 pm Purchase |
2025-02-28 | 13D | Whitehawk Therapeutics Inc WHWK |
Avoro Capital Advisors LLC | 11,914,961 19.990% |
8,333,000 (+232.64%) |
Filing History |
| 2025-02-24 11:38 am Unchanged |
2025-02-24 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:59 pm Sale |
2024-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Satter Muneer A | 659 0.000% |
-1,630,171 (-99.96%) |
Filing History |
| 2025-02-14 2:00 pm Purchase |
2024-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
QVT Financial LP | 2,313,702 9.370% |
2,313,702 (New Position) |
Filing History |
| 2025-02-14 12:11 pm Sale |
2024-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
EcoR1 Capital LLC | 345,253 1.400% |
-1,500,000 (-81.29%) |
Filing History |
| 2025-02-04 11:11 am Unchanged |
2025-02-03 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing History |
| 2025-01-30 3:32 pm Unchanged |
2025-01-30 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing History |
| 2025-01-29 7:01 pm Purchase |
2025-01-22 | 13G | Whitehawk Therapeutics Inc WHWK |
Point72 Asset Management, L.P. | 1,470,311 6.000% |
1,470,311 (New Position) |
Filing History |
| 2025-01-24 2:34 pm Purchase |
2024-12-19 | 13D | Whitehawk Therapeutics Inc WHWK |
ACUTA CAPITAL PARTNERS LLC | 1,921,297 7.800% |
373,216 (+24.11%) |
Filing History |
| 2024-12-31 11:13 am Purchase |
2024-12-31 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
1,051,183 (+75.96%) |
Filing History |
| 2024-12-23 5:26 pm Purchase |
2024-12-19 | 13D | Whitehawk Therapeutics Inc WHWK |
Desai Neil | 2,263,566 9.200% |
145,961 (+6.89%) |
Filing History |
| 2024-12-23 3:51 pm Purchase |
2024-12-19 | 13D | Whitehawk Therapeutics Inc WHWK |
Avoro Capital Advisors LLC | 3,581,961 14.500% |
110,209 (+3.17%) |
Filing History |
| 2024-10-01 5:35 pm Sale |
2024-10-01 | 13D | Whitehawk Therapeutics Inc WHWK |
Desai Neil | 2,117,605 8.500% |
-517,591 (-19.64%) |
Filing History |
| 2024-09-03 5:51 pm Purchase |
2024-08-23 | 13G | Whitehawk Therapeutics Inc WHWK |
EcoR1 Capital LLC | 1,845,253 7.500% |
1,845,253 (New Position) |
Filing History |